Ivermectin-benzimidazole prescribing following celebrity endorsement
After a January 2025 podcast promoted ivermectin with a dog dewormer as a cancer cure, US prescriptions of the combination doubled overall and rose 2.6-fold among people with cancer, most steeply in the South.
Overview
Using electronic records from 67 US health care organisations covering 68,373,949 patients, the authors compared same-day ivermectin plus benzimidazole prescribing from January to July 2025 with the same months of 2024 (Rockwell JAMA Network Open 2026). Overall prescribing doubled, rate ratio 1.97 with a 99.5 percent confidence interval of 1.70 to 2.29, and among patients with a cancer diagnosis it rose 2.63-fold, 99.5 percent confidence interval 2.08 to 3.24, with larger rises in men, in adults under 65, in White patients and in the South (Rockwell JAMA Network Open 2026). The authors note that no rigorous trial evidence supports ivermectin, fenbendazole or other benzimidazoles for cancer, and that the podcast was viewed more than 60 million times (Rockwell JAMA Network Open 2026).
- Combination prescribing doubled after the January 2025 endorsement: rate ratio 1.97 (99.5 percent CI 1.70 to 2.29).
- Among patients with cancer the rate ratio was 2.63 (99.5 percent CI 2.08 to 3.24); in the South, 3.91.
Measures the reach of the claim rather than the drug: tens of thousands of prescriptions written on the strength of a podcast, with no trial behind them.
- Observational; prescriptions ordered, not dispensed or taken; cannot show whether patients delayed conventional treatment.
Similar pages
not linked directly; found by shared links- TrialAtavistic chemotherapy: combinations of antibacterial, antifungal and antiprotozoal drugs in advanced cancer (Arguello clinic, status unknown)
Shares Fenbendazole, ivermectin and other internet 'repurposed cures', Mebendazole, Ivermectin, Misinformation and unproven therapies.
- Key paperCancer therapy using antiparasitic medications guided by acupuncture meridian assessment: a case series of six patients
Shares Fenbendazole, ivermectin and other internet 'repurposed cures', Mebendazole, Ivermectin, Misinformation and unproven therapies.
- Key paperRETRACTED: Fenbendazole as an anticancer agent? A case series of self-administration in three patients
Shares Fenbendazole (veterinary anthelmintic), Fenbendazole, ivermectin and other internet 'repurposed cures', Misinformation and unproven therapies.
- Key paperMetastatic melanoma with initial ctDNA decline and radiographic response during self-directed antiparasitic use: treatment effect or spontaneous regression?
Shares Fenbendazole (veterinary anthelmintic), Fenbendazole, ivermectin and other internet 'repurposed cures', Ivermectin.
- Key paperReal-world clinical outcomes of ivermectin and mebendazole in cancer patients: results from a prospective observational cohort (with 2026 expression of concern)
Shares Fenbendazole, ivermectin and other internet 'repurposed cures', Mebendazole, Ivermectin, Misinformation and unproven therapies.
- Key paperIvermectin treatment for gynecologic cancers: hope versus hype
Shares Fenbendazole, ivermectin and other internet 'repurposed cures', Ivermectin, Misinformation and unproven therapies.
- Key paperDrug-induced liver injury following co-ingestion of veterinary fenbendazole and ivermectin for prostate cancer: a case report
Shares Fenbendazole (veterinary anthelmintic), Ivermectin, Misinformation and unproven therapies.
- Key paperSevere drug-induced liver injury due to self-administration of the veterinary anthelmintic medication fenbendazole
Shares Fenbendazole (veterinary anthelmintic), Misinformation and unproven therapies.